Taho Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016	2016 - 2020
Period Ending	Aug '25 Aug 19, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2016 - 2020
Market Capitalization	6,861	2,274	-	-	616	549	Upgrade
Market Cap Growth	-	-	-	-	12.10%	-59.61%	Upgrade
Enterprise Value	6,473	2,074	-	-	430	279	Upgrade
Last Close Price	133.50	44.40	-	-	11.77	10.50	Upgrade
PS Ratio	881.94	-	-	-	49.65	15.25	Upgrade
PB Ratio	15.39	4.41	-	-	3.55	1.76	Upgrade
P/TBV Ratio	15.42	4.41	-	-	3.94	1.89	Upgrade
EV/Sales Ratio	-	-	-	-	34.70	7.75	Upgrade
Debt / Equity Ratio	0.03	0.03	0.11	-	0.01	0.00	Upgrade
Asset Turnover	0.02	-	0.01	-	0.05	0.09	Upgrade
Inventory Turnover	-	-	-	-	2.18	2.02	Upgrade
Quick Ratio	35.53	15.02	3.85	2.29	5.13	19.17	Upgrade
Current Ratio	35.74	15.09	3.91	2.39	5.70	20.53	Upgrade
Return on Equity (ROE)	-48.14%	-46.32%	-80.79%	-	-56.44%	-29.72%	Upgrade
Return on Assets (ROA)	-29.12%	-25.20%	-35.89%	-	-25.53%	-17.73%	Upgrade
Return on Capital (ROIC)	-29.66%	-27.94%	-47.25%	-	-27.51%	-18.50%	Upgrade
Earnings Yield	-2.42%	-7.36%	-	-	-22.27%	-19.88%	Upgrade
FCF Yield	-2.51%	-7.29%	-	-	-22.48%	-18.79%	Upgrade
Buyback Yield / Dilution	-17.56%	-17.18%	-7.73%	31.26%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.